Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: Promotion of dissemination, colonization, and metastatic growth

Clinical and Experimental Metastasis

Volumn 31, Issue 1, 2014, Pages 87-100

  Weinspach, Dirk ^a   Seubert, Bastian ^a   Schaten, Susanne ^a   Honert, Katja ^a   Sebens, Susanne ^b   Altevogt, Peter ^c   Krüger, Achim ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Dissemination; L1CAM; Metastatic cascade; Metastatic growth; MMPs; Targeted therapy

Indexed keywords

EID: 84894947633     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9613-6     Document Type: Article

References (54)

1. Sporn MB (1996) The war on cancer. Lancet 347:1377-1381
2. Fidler IJ (2003) The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 3:453-458
3. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275-292
4. Pals ST, de Gorter DJJ, Spaargaren M (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110:3102-3111
5. Noël A, Gutiérrez-Fernández A, Sounni NE et al (2012) New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front Pharmacol 3:140
6. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9-34
7. Mook ORF, Frederiks WM, Van Noorden CJF (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705:69-89
8. Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20:749-755
9. Dufour A, Zucker S, Sampson NS et al (2010) Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides. J Biol Chem 285:35944-35956
10. Dufour A, Sampson NS, Zucker S, Cao J (2008) Role of the hemopexin domain of matrix metalloproteinases in cell migration. J Cell Physiol 217:643-651
11. Chetty C, Vanamala SK, Gondi CS et al (2012) MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 24:549-559
12. Gerg M, Kopitz C, Schaten S et al (2008) Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases. Mol Cancer Res 6:341-351
13. Brown S, Bernardo M, Li Z-H (2000) Potent and selective mechanism-based inhibition of gelatinases. J Am Chem Soc 122:6799-6800
14. Krüger A, Arlt MJE, Gerg M et al (2005) Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 65:3523-3526
15. Westermarck J, Kähäri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13:781-792
16. Munshi HG, Stack MS (2006) Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25:45-56
17. Denzel S, Mack B, Eggert C et al (2012) MMP7 is a target of the tumour-associated antigen EpCAM. Int J Exp Pathol 93:341-353
18. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118-132
19. Kiefel H, Bondong S, Hazin J et al (2012) L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr 6:374-384
20. Wai Wong C, Dye DE, Coombe DR (2012) The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol 2012:340296
21. Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A (2008) L1-CAM in cancerous tissues. Expert Opin Biol Ther 8:1749-1757
22. Raveh S, Gavert N, Ben-Ze'ev A (2009) L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett 282:137-145
23. Fogel M, Gutwein P, Mechtersheimer S et al (2003) L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362:869-875
24. Schäfer H, Geismann C, Heneweer C et al (2012) Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent. Carcinogenesis 33:84-93
25. Gavert N, Sheffer M, Raveh S et al (2007) Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 67:7703-7712
26. Gavert N, Ben-Shmuel A, Lemmon V et al (2010) Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 123:2135-2143
27. Gavert N, Vivanti A, Hazin J et al (2011) L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9:14-24
28. Thies A, Schachner M, Moll I et al (2002) Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 38:1708-1716
29. Arlt MJE, Novak-Hofer I, Gast D et al (2006) Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66:936-943
30. Fischer E, Grünberg J, Cohrs S et al (2012) L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer. Int J Cancer 130:2715-2721
31. Knogler K, Grünberg J, Zimmermann K et al (2007) Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 13:603-611
32. Hai J, Zhu C-Q, Bandarchi B et al (2012) L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clin Cancer Res 18:1914-1924
33. Hung S-C, Wu I-H, Hsue S-S et al (2010) Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma. Mol Pharm 7:2312-2323
34. Krüger A, Schirrmacher V, von Hoegen P (1994) Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58:275-284
35. Soneoka Y, Cannon PM, Ramsdale EE et al (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23:628-633
36. Yee JK, Miyanohara A, LaPorte P et al (1994) A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 91:9564-9568
37. Kopitz C, Anton M, Gansbacher B, Krüger A (2005) Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 65:8608-8612
38. Krüger A, Umansky V, Rocha M et al (1994) Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84:3166-3174
39. Arlt M, Kopitz C, Pennington C et al (2002) Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res 62:5543-5550
40. Wolterink S, Moldenhauer G, Fogel M et al (2010) Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res 70:2504-2515
41. Gast D, Riedle S, Riedle S et al (2005) L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 115:658-665
42. Gast D, Riedle S, Issa Y et al (2008) The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 27:1281-1289
43. Zhang H, Wong CCL, Wei H et al (2012) HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31:1757-1770
44. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572
45. Luzzi KJ, MacDonald IC, Schmidt EE et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865-873
46. Sebens Müerköster S, Werbing V, Sipos B et al (2007) Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 26:2759-2768
47. Stoeck A, Gast D, Sanderson MP et al (2007) L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 104:461-469
48. Bergmann F, Wandschneider F, Sipos B et al (2010) Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncol Rep 24:909-915
49. Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992-1009
50. Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8:629-642
51. Björklund M, Koivunen E (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755:37-69
52. Gavert N, Conacci-Sorrell M, Gast D et al (2005) L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168:633-642
53. Tsutsumi S, Morohashi S, Kudo Y et al (2011) L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J Surg Oncol 103:669-673
54. Zecchini S, Bianchi M, Colombo N et al (2008) The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 68:1110-1118